Atlas Trials

The Effect of Nasal Carbon Dioxide in the Treatment of Moderate to Severe Migraine

Clinical trial NCT01253915 · TERMINATED

Trial details

NCT number
NCT01253915
Sponsor
Capnia, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Migraine
Start date
2012-01-01
Primary completion
2013-04-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.